改良肌酐指数对接受血液透析治疗的个体全因死亡率的纵向影响。

IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Annals of Saudi Medicine Pub Date : 2021-11-01 Epub Date: 2021-12-02 DOI:10.5144/0256-4947.2021.361
Koray Uludag, Tamer Arikan
{"title":"改良肌酐指数对接受血液透析治疗的个体全因死亡率的纵向影响。","authors":"Koray Uludag,&nbsp;Tamer Arikan","doi":"10.5144/0256-4947.2021.361","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The modified creatinine index (mCI), as a surrogate marker of muscle mass, has been associated with poor outcomes in patients undergoing hemodialysis. However, a single assessment may not reflect the clinical significance before an adverse clinical endpoint.</p><p><strong>Objective: </strong>Analyze mCI trajectories and their association with all-cause mortality in incident hemodialysis patients.</p><p><strong>Design: </strong>Retrospective observational cohort.</p><p><strong>Setting: </strong>Outpatient dialysis facility.</p><p><strong>Patients and methods: </strong>We followed a cohort of patients who underwent maintenance hemodialysis treatment at least three times weekly for at least three months from 19 June 2010 to 29 December 2017. Clinical and laboratory features were measured at baseline. Longitudinal changes in the mCI were modeled using a joint longitudinal and survival model adjusted for baseline covariates and body mass index trajectories.</p><p><strong>Main outcome measure: </strong>All-cause mortality.</p><p><strong>Sample size: </strong>408 with 208 males (50.7%).</p><p><strong>Results: </strong>The mean (SD) age was 62.2 (12.3) years. The mCI changes were evaluated for a median (interquartile range) follow-up of 2.16 (1.13, 3.73) years. Forty-six percent (n=188) of patients reached the endpoint. A steeper slope (per 0.1 unit increase in the decrease rate) in modified creatinine index was associated with increased risk of all-cause mortality (HR, 1.04; 95% CI, 1.02-1.07; <i>P</i>=.011). In addition, an annual 1 mg/kg/day decrease in modified creatinine index level increased the hazard of all-cause mortality by 4% (HR, 1.04; 95% CI, 1.02-1.07; <i>P</i>=.001).</p><p><strong>Limitations: </strong>Residual kidney function was not observed in the data. Setting was single center and thus results may not be generalizable to other populations.</p><p><strong>Conclusion: </strong>All-cause death was significantly associated with loss of muscle mass over time. Longitudinal trajectories of nutritional markers may predict the clinical outcomes in patients undergoing hemodialysis. This may also be valuable for individual risk stratification. Furthermore, early management may provide an opportunity to improve patient survival.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"41 6","pages":"361-368"},"PeriodicalIF":1.5000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/08/44/0256-4947.2021.361.PMC8650593.pdf","citationCount":"0","resultStr":"{\"title\":\"Longitudinal effects of modified creatinine index on all-cause mortality in individuals receiving hemodialysis treatment.\",\"authors\":\"Koray Uludag,&nbsp;Tamer Arikan\",\"doi\":\"10.5144/0256-4947.2021.361\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The modified creatinine index (mCI), as a surrogate marker of muscle mass, has been associated with poor outcomes in patients undergoing hemodialysis. However, a single assessment may not reflect the clinical significance before an adverse clinical endpoint.</p><p><strong>Objective: </strong>Analyze mCI trajectories and their association with all-cause mortality in incident hemodialysis patients.</p><p><strong>Design: </strong>Retrospective observational cohort.</p><p><strong>Setting: </strong>Outpatient dialysis facility.</p><p><strong>Patients and methods: </strong>We followed a cohort of patients who underwent maintenance hemodialysis treatment at least three times weekly for at least three months from 19 June 2010 to 29 December 2017. Clinical and laboratory features were measured at baseline. Longitudinal changes in the mCI were modeled using a joint longitudinal and survival model adjusted for baseline covariates and body mass index trajectories.</p><p><strong>Main outcome measure: </strong>All-cause mortality.</p><p><strong>Sample size: </strong>408 with 208 males (50.7%).</p><p><strong>Results: </strong>The mean (SD) age was 62.2 (12.3) years. The mCI changes were evaluated for a median (interquartile range) follow-up of 2.16 (1.13, 3.73) years. Forty-six percent (n=188) of patients reached the endpoint. A steeper slope (per 0.1 unit increase in the decrease rate) in modified creatinine index was associated with increased risk of all-cause mortality (HR, 1.04; 95% CI, 1.02-1.07; <i>P</i>=.011). In addition, an annual 1 mg/kg/day decrease in modified creatinine index level increased the hazard of all-cause mortality by 4% (HR, 1.04; 95% CI, 1.02-1.07; <i>P</i>=.001).</p><p><strong>Limitations: </strong>Residual kidney function was not observed in the data. Setting was single center and thus results may not be generalizable to other populations.</p><p><strong>Conclusion: </strong>All-cause death was significantly associated with loss of muscle mass over time. Longitudinal trajectories of nutritional markers may predict the clinical outcomes in patients undergoing hemodialysis. This may also be valuable for individual risk stratification. Furthermore, early management may provide an opportunity to improve patient survival.</p><p><strong>Conflict of interest: </strong>None.</p>\",\"PeriodicalId\":8016,\"journal\":{\"name\":\"Annals of Saudi Medicine\",\"volume\":\"41 6\",\"pages\":\"361-368\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2021-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/08/44/0256-4947.2021.361.PMC8650593.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Saudi Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5144/0256-4947.2021.361\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/12/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Saudi Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5144/0256-4947.2021.361","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/12/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:改良肌酐指数(mCI)作为肌肉质量的替代指标,与血液透析患者的不良预后相关。然而,在不良临床终点出现之前,单一评估可能无法反映临床意义。目的:分析血透患者mCI的发展轨迹及其与全因死亡率的关系。设计:回顾性观察队列。环境:门诊透析设施。患者和方法:从2010年6月19日至2017年12月29日,我们随访了一组接受维持性血液透析治疗的患者,每周至少三次,持续至少三个月。在基线时测量临床和实验室特征。mCI的纵向变化采用经基线协变量和体重指数轨迹调整的联合纵向和生存模型进行建模。主要结局指标:全因死亡率。样本量:408人,其中男性208人(50.7%)。结果:平均(SD)年龄为62.2(12.3)岁。mCI变化的中位(四分位数范围)随访时间为2.16年(1.13年,3.73年)。46% (n=188)的患者达到了终点。修正肌酐指数的斜率越陡(下降率每增加0.1个单位),全因死亡风险越高(HR, 1.04;95% ci, 1.02-1.07;P = .011)。此外,改良肌酐指数水平每降低1 mg/kg/天,全因死亡风险增加4% (HR, 1.04;95% ci, 1.02-1.07;P =措施)。局限性:在数据中未观察到残留的肾功能。设置为单中心,因此结果可能无法推广到其他人群。结论:随着时间的推移,全因死亡与肌肉量的减少显著相关。营养指标的纵向轨迹可以预测血液透析患者的临床结果。这对于个体风险分层也很有价值。此外,早期治疗可能提供提高患者生存率的机会。利益冲突:无。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Longitudinal effects of modified creatinine index on all-cause mortality in individuals receiving hemodialysis treatment.

Longitudinal effects of modified creatinine index on all-cause mortality in individuals receiving hemodialysis treatment.

Longitudinal effects of modified creatinine index on all-cause mortality in individuals receiving hemodialysis treatment.

Background: The modified creatinine index (mCI), as a surrogate marker of muscle mass, has been associated with poor outcomes in patients undergoing hemodialysis. However, a single assessment may not reflect the clinical significance before an adverse clinical endpoint.

Objective: Analyze mCI trajectories and their association with all-cause mortality in incident hemodialysis patients.

Design: Retrospective observational cohort.

Setting: Outpatient dialysis facility.

Patients and methods: We followed a cohort of patients who underwent maintenance hemodialysis treatment at least three times weekly for at least three months from 19 June 2010 to 29 December 2017. Clinical and laboratory features were measured at baseline. Longitudinal changes in the mCI were modeled using a joint longitudinal and survival model adjusted for baseline covariates and body mass index trajectories.

Main outcome measure: All-cause mortality.

Sample size: 408 with 208 males (50.7%).

Results: The mean (SD) age was 62.2 (12.3) years. The mCI changes were evaluated for a median (interquartile range) follow-up of 2.16 (1.13, 3.73) years. Forty-six percent (n=188) of patients reached the endpoint. A steeper slope (per 0.1 unit increase in the decrease rate) in modified creatinine index was associated with increased risk of all-cause mortality (HR, 1.04; 95% CI, 1.02-1.07; P=.011). In addition, an annual 1 mg/kg/day decrease in modified creatinine index level increased the hazard of all-cause mortality by 4% (HR, 1.04; 95% CI, 1.02-1.07; P=.001).

Limitations: Residual kidney function was not observed in the data. Setting was single center and thus results may not be generalizable to other populations.

Conclusion: All-cause death was significantly associated with loss of muscle mass over time. Longitudinal trajectories of nutritional markers may predict the clinical outcomes in patients undergoing hemodialysis. This may also be valuable for individual risk stratification. Furthermore, early management may provide an opportunity to improve patient survival.

Conflict of interest: None.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Annals of Saudi Medicine
Annals of Saudi Medicine 医学-医学:内科
CiteScore
2.80
自引率
0.00%
发文量
44
审稿时长
4-8 weeks
期刊介绍: The Annals of Saudi Medicine (ASM) is published bimonthly by King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. We publish scientific reports of clinical interest in English. All submissions are subject to peer review by the editorial board and by reviewers in appropriate specialties. The journal will consider for publication manuscripts from any part of the world, but particularly reports that would be of interest to readers in the Middle East or other parts of Asia and Africa. Please go to the Author Resource Center for additional information.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信